Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging
Clement Torrent, Caterina Gagliardi, Nina Fülle, Ignazio Antignano, María Eugenia Bernis, Miriam Stork, Daniele Bano, Melania Capasso, Lily Keane
This study shows that long-term low-dose rapamycin reduces IL-17-producing gamma delta T cells and neuroinflammation in aging.
PLoS ONE · May 28, 2026Peer-reviewedImmunology